These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 19808497)

  • 1. Risk of failure of transvenous implantable cardioverter-defibrillator leads.
    Borleffs CJ; van Erven L; van Bommel RJ; van der Velde ET; van der Wall EE; Bax JJ; Rosendaal FR; Schalij MJ
    Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):411-6. PubMed ID: 19808497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management.
    Eckstein J; Koller MT; Zabel M; Kalusche D; Schaer BA; Osswald S; Sticherling C
    Circulation; 2008 May; 117(21):2727-33. PubMed ID: 18490526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does size really matter? A comparison of the Riata lead family based on size and its relation to performance.
    Corbisiero R; Armbruster R
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):722-6. PubMed ID: 18507545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of complications in patients with implantable cardioverter/defibrillator who receive additional transvenous pace/sense leads.
    Wollmann CG; Böcker D; Löher A; Köbe J; Scheld HH; Breithardt GE; Gradaus R
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):795-800. PubMed ID: 16105007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent risk of Fidelis lead failure.
    Faulknier BA; Traub DM; Aktas MK; Aguila A; Rosero S; Daubert JP; Hall B; Shah A; Taylor S; McNitt S; Moss AJ; Zareba W; Huang DT
    Am J Cardiol; 2010 Jan; 105(1):95-9. PubMed ID: 20102898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
    Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
    Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
    Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with transvenous implantable cardioverter-defibrillators for treatment of malignant ventricular arrhythmias.
    Jadonath RL; Pogo GJ; Goldner BG; Kalenderian D; Merkatz K; Cohen MB; Snow JS; Cohen TJ
    J Invasive Cardiol; 1995 Apr; 7(3):72-9. PubMed ID: 10155366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of replacing implantable devices in response to advisories: a single center experience.
    Moore JW; Barrington W; Bazaz R; Jain S; Nemec J; Ngwu O; Schwartzman D; Shalaby A; Saba S
    Int J Cardiol; 2009 May; 134(1):42-6. PubMed ID: 18372058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of lead safety recommendations.
    VAN Rees JB; Borleffs CJ; Bax JJ; Nagtegaal EM; VAN DER Velde ET; VAN Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):431-6. PubMed ID: 19954503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE; Gleva MJ; Mela T; Chung MK; Uslan DZ; Borge R; Gottipaty V; Shinn T; Dan D; Feldman LA; Seide H; Winston SA; Gallagher JJ; Langberg JJ; Mitchell K; Holcomb R;
    Circulation; 2010 Oct; 122(16):1553-61. PubMed ID: 20921437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and survival of transvenous defibrillation leads: need for a European data registry.
    Goette A; Cantu F; van Erven L; Geelen P; Halimi F; Merino JL; Morgan JM;
    Europace; 2009 Jan; 11(1):31-4. PubMed ID: 19004838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes in patients with abandoned versus extracted implantable cardioverter defibrillator leads.
    Amelot M; Foucault A; Scanu P; Gomes S; Champ-Rigot L; Pellissier A; Milliez P
    Arch Cardiovasc Dis; 2011 Nov; 104(11):572-7. PubMed ID: 22117909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.